Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Feb;144(3):446-7; author reply 447-8.
doi: 10.1111/j.1365-2141.2008.07002.x. Epub 2008 Dec 10.

Lenalidomide in renal insufficiency--balancing the risks and benefits

Ivan Borrello
Comment

Lenalidomide in renal insufficiency--balancing the risks and benefits

Ivan Borrello. Br J Haematol. 2009 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Chen N, Lau H, Kong L, Zeldis J, Knight R, Laskin O. Pharmacokinetics of lenalidomide in subjects with various degrees of renal function. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. 2007;25(Suppl 18S) Abstract 2520. - PubMed
    1. Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. European Journal of Haematology. 2000;65:175–181. - PubMed
    1. Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. Journal of Clinical Oncology. 2007;25:1993–1999. - PubMed
    1. Niesvizky R, Naib T, Christos PJ, Jayabalan D, Furst JR, Jalbrzikowski J, Zafar F, Tomer M, Lent R, Pearse RN, Ely S, Leonard JP, Mazumdar M, Chen-Kiang S, Coleman M. Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. British Journal of Haematology. 2007;138:640–643. - PubMed
    1. Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR Eastern Cooperative Oncology Group. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 2006;24:431–436. - PubMed